Feedback / Questions
Vyznova (neltependocel) - Aurion Biotech
https://www.businesswire.com/news/home/20251018009011/en/Aurion-Biotech-Achieves-All-Primary-Secondary-and-Exploratory-Endpoints-in-AURN001-Phase-12-CLARA-Trial-at-12-Months
Oct 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next